PMID- 21459437 OWN - NLM STAT- MEDLINE DCOM- 20110829 LR - 20191210 IS - 1878-5905 (Electronic) IS - 0142-9612 (Linking) VI - 32 IP - 21 DP - 2011 Jul TI - The role of bFGF in down-regulating alpha-SMA expression of chondrogenically induced BMSCs and preventing the shrinkage of BMSC engineered cartilage. PG - 4773-81 LID - 10.1016/j.biomaterials.2011.03.020 [doi] AB - Bone marrow stromal cells (BMSCs) have proved to be an ideal cell source for cartilage regeneration. Our previous studies demonstrated that a three-dimensional (3D) cartilage could be constructed successfully in vitro using BMSCs and biodegradable scaffolds. However, an obvious shrinkage and deformation was observed during in vitro chondrogenic induction. According to the literatures, it can be speculated that the up-regulation of smooth muscle actin-alpha (alpha-SMA) caused by transforming growth factor beta (TGFbeta) is one of the leading reasons and that basic fibroblast growth factor (bFGF) could antagonize the role of TGFbeta to down-regulate alpha-SMA expression and prevent the shrinkage of BMSC engineered cartilage. This study testified these speculations by adding bFGF to chondrogenic media. According to the current results, chondrogenic induction significantly up-regulated alpha-SMA expression of BMSCs at both cell and tissue levels, and the engineered tissue only retained 12.4% of original size after 6 weeks of chondrogenic induction. However, the supplement of bFGF in chondrogenic media efficiently down-regulated alpha-SMA expression and the engineered tissue still retained over 60% of original size after 6 weeks of culture. Moreover, bFGF showed a beneficial influence on 3D cartilage formation of BMSCs in terms of gene expression and deposition of cartilage specific matrices. All these results suggested that bFGF could repress alpha-SMA expression caused by chondrogenic induction, efficiently prevent shrinkage of BMSC engineered tissue, and have a positive influence on cartilage formation, which provides a clue for both shape control and quality improvement of BMSC engineered 3D cartilage. CI - Copyright (c) 2011 Elsevier Ltd. All rights reserved. FAU - Li, Qiong AU - Li Q AD - Department of Plastic and Reconstructive Surgery, Shanghai 9th People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai Key Laboratory of Tissue Engineering, Shanghai Stem Cell Institute, 639 Zhi Zao Ju Road, Shanghai 200011, PR China. FAU - Liu, Tianyi AU - Liu T FAU - Zhang, Lu AU - Zhang L FAU - Liu, Yu AU - Liu Y FAU - Zhang, Wenjie AU - Zhang W FAU - Liu, Wei AU - Liu W FAU - Cao, Yilin AU - Cao Y FAU - Zhou, Guangdong AU - Zhou G LA - eng PT - Evaluation Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20110402 PL - Netherlands TA - Biomaterials JT - Biomaterials JID - 8100316 RN - 0 (Actins) RN - 0 (Biocompatible Materials) RN - 0 (Culture Media) RN - 103107-01-3 (Fibroblast Growth Factor 2) SB - IM MH - Actins/genetics/*metabolism MH - Animals MH - Biocompatible Materials/chemistry/metabolism MH - Bone Marrow Cells/cytology/*drug effects/*physiology MH - Cartilage/*cytology MH - Cell Culture Techniques MH - Cell Proliferation MH - Cells, Cultured MH - Chondrogenesis/drug effects MH - Culture Media/chemistry MH - Fibroblast Growth Factor 2/*pharmacology MH - Materials Testing MH - Stromal Cells/cytology/*drug effects/*physiology MH - Swine MH - Tissue Engineering/methods MH - Tissue Scaffolds/chemistry EDAT- 2011/04/05 06:00 MHDA- 2011/08/30 06:00 CRDT- 2011/04/05 06:00 PHST- 2011/02/20 00:00 [received] PHST- 2011/03/06 00:00 [accepted] PHST- 2011/04/05 06:00 [entrez] PHST- 2011/04/05 06:00 [pubmed] PHST- 2011/08/30 06:00 [medline] AID - S0142-9612(11)00262-6 [pii] AID - 10.1016/j.biomaterials.2011.03.020 [doi] PST - ppublish SO - Biomaterials. 2011 Jul;32(21):4773-81. doi: 10.1016/j.biomaterials.2011.03.020. Epub 2011 Apr 2.